3,902 Shares in Silicon Laboratories, Inc. (NASDAQ:SLAB) Bought by Calamos Advisors LLC

Calamos Advisors LLC purchased a new stake in Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,902 shares of the semiconductor company's stock, valued at approximately $439,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Jones Financial Companies Lllp increased its position in shares of Silicon Laboratories by 44.5% during the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 69 shares in the last quarter. UMB Bank n.a. increased its position in shares of Silicon Laboratories by 111.3% during the first quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock worth $38,000 after purchasing an additional 177 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of Silicon Laboratories by 143.7% during the first quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock worth $52,000 after buying an additional 273 shares during the last quarter. Headlands Technologies LLC purchased a new position in shares of Silicon Laboratories during the fourth quarter worth about $70,000. Finally, GAMMA Investing LLC grew its holdings in shares of Silicon Laboratories by 99.6% during the first quarter. GAMMA Investing LLC now owns 1,126 shares of the semiconductor company's stock worth $127,000 after buying an additional 562 shares during the last quarter.

Analysts Set New Price Targets

SLAB has been the topic of a number of analyst reports. KeyCorp lifted their price objective on Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a report on Tuesday. Stifel Nicolaus lowered their price objective on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. Benchmark reissued a "buy" rating and set a $160.00 price objective on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Susquehanna boosted their price objective on shares of Silicon Laboratories from $100.00 to $110.00 and gave the company a "neutral" rating in a research note on Wednesday, May 14th. Finally, Barclays decreased their price objective on shares of Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 22nd. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, Silicon Laboratories currently has an average rating of "Moderate Buy" and a consensus price target of $129.00.

Silicon Laboratories Price Performance

Shares of Silicon Laboratories stock traded up $1.16 on Wednesday, hitting $141.32. The company had a trading volume of 488,688 shares, compared to its average volume of 351,344. The business has a 50-day simple moving average of $131.83 and a 200-day simple moving average of $127.14. The company has a market cap of $4.60 billion, a PE ratio of -27.66 and a beta of 1.47. Silicon Laboratories, Inc. has a 52 week low of $82.82 and a 52 week high of $160.00.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.01. The firm had revenue of $177.71 million during the quarter, compared to analysts' expectations of $177.48 million. Silicon Laboratories had a negative net margin of 25.16% and a negative return on equity of 8.80%. The firm's revenue for the quarter was up 67.0% compared to the same quarter last year. During the same period last year, the firm posted ($0.92) earnings per share. On average, equities research analysts predict that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Christy Wyatt sold 546 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $104.45, for a total value of $57,029.70. Following the completion of the transaction, the director owned 8,492 shares of the company's stock, valued at approximately $886,989.40. This trade represents a 6.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Robert Matthew Johnson sold 5,879 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $131.20, for a total transaction of $771,324.80. Following the completion of the sale, the chief executive officer owned 73,688 shares of the company's stock, valued at approximately $9,667,865.60. The trade was a 7.39% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 11,626 shares of company stock valued at $1,509,319. Company insiders own 1.60% of the company's stock.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.